190,640 Shares in Maximus, Inc. $MMS Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. purchased a new position in shares of Maximus, Inc. (NYSE:MMS – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 190,640 shares of the health services provider’s stock, valued at approximately $10,140,000. Edgestream Partners L.P. owned approximately 0.36% of Maximus as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Bessemer Group Inc. grew its stake in shares of Maximus by 45.1% in the third quarter. Bessemer Group Inc. now owns 515 shares of the health services provider’s stock valued at $27,000 after buying an additional 160 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Maximus by 0.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 31,919 shares of the health services provider’s stock valued at $1,698,000 after buying an additional 195 shares during the period. Allworth Financial LP raised its holdings in shares of Maximus by 60.8% in the 3rd quarter. Allworth Financial LP now owns 645 shares of the health services provider’s stock valued at $35,000 after buying an additional 244 shares during the period. Root Financial Partners LLC purchased a new stake in shares of Maximus in the 3rd quarter valued at $26,000. Finally, Covestor Ltd raised its holdings in shares of Maximus by 33.2% in the 3rd quarter. Covestor Ltd now owns 2,199 shares of the health services provider’s stock valued at $117,000 after buying an additional 548 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

MMS has been the subject of a number of research analyst reports. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Maximus in a research note on Friday. Finally, Zacks Research upgraded shares of Maximus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 1st. Two investment analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

Read Our Latest Analysis on MMS

Insider Buying and Selling

In other Maximus news, insider Michelle Link sold 3,208 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total transaction of $173,969.84. Following the completion of the transaction, the insider owned 13,881 shares in the company, valued at $752,766.63. The trade was a 18.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.80% of the stock is owned by company insiders.

Maximus Stock Up 0.9%

MMS stock opened at $65.32 on Tuesday. The company’s 50 day moving average price is $59.63 and its 200 day moving average price is $63.41. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. Maximus, Inc. has a fifty-two week low of $51.04 and a fifty-two week high of $100.00. The firm has a market capitalization of $3.42 billion, a price-to-earnings ratio of 9.65 and a beta of 0.57.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 2.0%. The ex-dividend date is Friday, November 13th. Maximus’s payout ratio is 19.50%.

Maximus Company Profile

(Free Report)

Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.

Recommended Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.